Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2000
08/23/2000EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use
08/23/2000EP1028715A1 Dosage composition for nasal delivery and method of use of the same
08/23/2000EP1028626A1 Method for the augmentation of gene expression
08/23/2000EP0729473B1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
08/23/2000EP0686039B1 Method of enhancing immune response to oral vaccines
08/23/2000EP0667859B1 Molecule labelling using 2-hydraninopyridine derivatives
08/23/2000CN1264427A Osteoprotegernin binding proteins and receptors
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
08/23/2000CN1264423A Cytoxtoxic T lymphocytes
08/23/2000CN1264422A Immunity enhancing lactic acid bacteria
08/23/2000CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use
08/23/2000CN1055726C Reconstituted body vaccine and method for prepn. thereof
08/23/2000CN1055702C Extraction of cell-bound protein from bordetella
08/23/2000CN1055701C Piptide capable of inducing immune response against HIV and edicine for AIDS preventive and remedy containing the peptide
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
08/22/2000US6107464 iceA gene and related methods
08/22/2000US6107463 Amino acid sequence of protein involved in bacterial two component signal transduction systems; bactericides and bacteriostats especially against staphylococcus
08/22/2000US6107090 Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
08/22/2000US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
08/22/2000US6107077 Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6107021 Peptides for use as immunogens in mammals to produce polyclonal antibodies for the prevention of viral diseases
08/22/2000US6106844 Administering to venom allergic patient
08/22/2000US6106843 Process for the isolation of a nontoxinogenic vibrio cholerae strain and a process for preparing cholera vaccine from said vibrio cholerae strain
08/22/2000US6106842 Extraction of cell-bound protein from bordetella
08/22/2000US6106841 Delivery method for recombinant raccoon poxvirus
08/22/2000US6106840 Autoimmune diseases
08/22/2000US6106836 Container with freeze-dried vaccine components
08/22/2000US6106834 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
08/22/2000US6106832 Treating x-linked hyper igm syndrome and combined variable immunodeficiency syndrome
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2050343C Matrix metalloproteinase peptides: role in diagnosis and therapy
08/17/2000WO2000047756A1 Recombined porcine adenovirus based viral vaccines and vectors
08/17/2000WO2000047744A1 Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope
08/17/2000WO2000047737A1 Haemophilus influenzae rd outer membrane sequences used as vaccine
08/17/2000WO2000047722A2 Chimeric virus-like particles or chimeric capsomers from bvp (bovine papilloma virus)
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047613A1 Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit
08/17/2000WO2000047609A1 Cyclic peptides and aids vaccines
08/17/2000WO2000047240A1 Methods of inactivating pathogens using broad-spectrum pulsed light
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047228A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
08/17/2000WO2000047227A2 Mycobacterium tuberculosis, immunization
08/17/2000WO2000047226A1 Tumor vaccines
08/17/2000WO2000047224A2 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047222A2 Inactivated influenza virus vaccine for nasal or oral administration
08/17/2000WO2000047216A1 Immunogenic compositions for use as vaccines
08/17/2000WO2000047186A1 Polynucleotide compositions for intramuscular and intradermal administration
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000033870A3 New cancer treatments
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000026375A3 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
08/17/2000WO2000026374A3 Adipose specific protein
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000016708A9 Methods and systems for treating breast tissue
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO1998015626A3 Mutant ciita molecule and uses thereof
08/17/2000DE19905883A1 Chimäre Virus-ähnliche Partikel bzw. chimäre Capsomere von BPV Chimeric virus-like particles or chimeric capsomeres of BPV
08/17/2000DE19904650A1 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequence of an interactor FANCIP1 of the Fanconi anemia complementation group A protein
08/17/2000CA2364615A1 Haemophilus influenzae rd outer membrane sequences used as vaccine
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362578A1 Tumor vaccines
08/17/2000CA2362525A1 Cyclic peptides and aids vaccines
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2360292A1 Immunogenic compositions for use as vaccines
08/17/2000CA2360131A1 Methods of inactivating pathogens using broad-spectrum pulsed light
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2359886A1 Polynucleotide compositions for intramuscular and intradermal administration
08/17/2000CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response
08/16/2000EP1027896A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
08/16/2000EP1027895A2 Erysipelothrix rhusiopathiae antigens and vaccine compositions
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027439A2 Multivalent antigen-binding proteins
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
08/16/2000EP1027435A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027375A1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
08/16/2000EP1027078A1 IMMUNIZATION AGAINST $i(STREPTOCOCCUS PNEUMONIAE) USING CONJUGATED AND UNCONJUGATED PNEUMOCOCCAL POLYSACCHARIDE VACCINES
08/16/2000EP1027074A1 Compositions and methods for delivery of genetic material
08/16/2000EP1027071A2 Encapsulated immunomodulators useful as vaccine adjuvants
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027063A1 Mannose receptor bearing cell line and antigen composition
08/16/2000EP1027061A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
08/16/2000EP1026949A1 Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
08/16/2000CN1263598A Antibodies and SCFV immunotoxins specific to imported fire ants, and their application
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263470A Immunopotentiating composition
08/16/2000CN1262958A Method for enhancing antigenicity of antigen being in vaccine preparation by using quillaira saponaria soponin adjuvant
08/16/2000CN1055501C Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus
08/16/2000CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
1 ... 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 ... 1823